logo

Get Latest Updates

Stay updated with our instant notification.

logo
logo
account_circle Login
BioSpectrum India Magazine
BioSpectrum India Magazine

BioSpectrum India Magazine

By: Bio Spectrum And NuFFooDs Spectrum
100.00

Single Issue

1250.00

12 Months

100.00

Single Issue

1250.00

12 Months

About this issue

INDIAN BIOPHARMA HITS RS 25,000 CRORE RIDING 15% GROWTH WAVE     The Indian Biopharma Industry, with over 300 companies, is growing at the rate of 15 per cent, which is 3 per cent more than the previous year’s 12 per cent. This growth was largely driven by over 20 per cent growth rate recorded by 8 of the top 20 companies in the biopharma space. As a result, the Indian Biopharma Industry has crossed the Rs 25,000 crore mark for the year 2019-20 over the previous year’s figure of Rs 22,124 crore. In 2017-18 the industry recorded a revenue of Rs 18,290 crore. The Indian Biopharma industry, comprising hormones, insulin, blood products and vaccines recorded a sales revenue of Rs 25,442 crore for the year 2019-20.    

About BioSpectrum India Magazine

The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc